| abstract |
The object of the present invention is to improve the resistance to moisture and to improve the storage stability of a dry powder formulation for inhalation. In order to improve moisture resistance and improve storage stability for dry powder formulations for inhalation, the present formulation comprises a non-inhaled particle size pharmaceutically active carrier, and an inhaled size Containing finely pulverized pharmaceutically active compounds. For improvement, magnesium stearate is used. One characteristic of the dry powder of the present invention is that it can be maintained at high and relatively extreme temperature and humidity conditions. [Selection figure] None |